Once a widely-used antipsychotic medication, Risperdal – introduced in the United States by Johnson & Johnson in 1993 – has been plagued in recent years by FDA warnings and lawsuits over side effects and J&J’s questionable Risperdal marketing practices. To date, Johnson & Johnson faces hundreds of complaints brought on behalf of individuals who have suffered side effects like gynecomastia (breast growth in boys), heart attack and stroke during or after Risperdal treatment. In addition, J&J has faced significant criticism over its attempts to promote Risperdal as a treatment for behavior disorders in children and dementia in the elderly, at a time when neither use was approved by the FDA. If you have experienced a side effect like heart attack or gynecomastia, and you believe J&J’s Risperdal antipsychotic to be the cause, fill out the case review form to discuss your legal options with a qualified Risperdal attorney.
Antipsychotics are some of the most widely-prescribed medications in the United States, and Risperdal alone accounts for nearly one-quarter of the more than 50 million antipsychotic prescriptions filled every year. Unfortunately, many individuals who take Risperdal as a treatment for schizophrenia or bipolar disorder are unaware of the side effects they may be exposing themselves to by using the atypical antipsychotic. The most common side effects allegedly linked to Risperdal include:
If you or loved one has suffered from a devastating side effect of Risperdal, like male breast growth, fill out the case review form now to speak to a qualified Risperdal attorney for free.
Perhaps the most disturbing adverse effect of Risperdal treatment is the atypical antipsychotic’s ability to cause abnormal breast growth in boys and young men. According to mounting research, Risperdal treatment may cause an increase in levels of prolactin, a hormone that stimulates breast growth in women. In male Risperdal patients, elevated prolactin levels may cause abnormal breast growth, a condition known as gynecomastia, which is sometimes accompanied by pain and nipple discharge. In 2006, a study published in the Journal of Clinical Psychopharmacology explored the potential connection between Risperdal and gynecomastia and found that the drug “administered to adolescents at doses commonly used for the treatment of psychotic symptoms can strongly increase prolactin levels, with clinical consequences such as gynecomastia.”
The side effects allegedly tied to Risperdal treatment can be devastating, especially gynecomastia, which has been shown to cause psychological trauma in victims, and may even require surgery to remove the abnormal breast tissue. As Risperdal lawsuits filed against Johnson & Johnson continue to mount, the drug company has already settled numerous complaints, including a $2.2 billion lawsuit filed by the U.S. Justice Department over Johnson & Johnson’s improper Risperdal marketing practices. If you believe you have been adversely affected by side effects of Risperdal, fill out the case review form to discuss your case with a reputable product liability lawyer. With an experienced Risperdal attorney on your side, you can protect your legal rights and seek fair and timely reimbursement for your injuries, medical expenses, and pain and suffering.
THIS IS AN ADVERTISEMENT
You should consult a physician or doctor before starting or stopping any medication. This website is a free matching service only and is not responsible for services or information from third party providers. This site does not provide tax or legal advice, and services are not available in all states.
This website is not affiliated in any way with Risperdal. Risperdal is a registered trademark of Janssen-Cliag, a Johnson & Johnson company.